Alejandro Galindo - EVP Endocrine Business Unit at MANNKIND CORP

Issuer-level insider activity

Role
EVP Endocrine Business Unit
Issuer symbol
MNKD on Nasdaq
Identity 1 identity field
Entity type
Individual
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by Alejandro Galindo since 02 Jun 2025

Reported holdings for Alejandro Galindo in MANNKIND CORP

Form 4 holding EVP Endocrine Business Unit

MANNKIND CORP

Security class
Common Stock, $0.01 Par Value
Shares / value
777,075
Estimated value
$3,108,300
Report date
22 Aug 2022
Price
$4.00
Ownership
Direct

Transaction history for Alejandro Galindo in MANNKIND CORP

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .